Brimonidine
Product Images NDC 17478-715

3 FDA label images from Akorn · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine (NDC 17478-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Bri01 0007 01)

Structural Formula (Bri01 0007 01)
Chemical structure diagram depicting the molecular formula of the active ingredient Brimonidine, showing its heterocyclic structure with bromine substitution and additional molecular components.*
FDA Label Image

Principal Display Panel Text For Container Label (Bri01 0007 02)

Principal Display Panel Text For Container Label (Bri01 0007 02)
Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, sterile eye drop solution in a 5 mL bottle. Contains active ingredient Brimonidine Tartrate 0.2% with preservative Benzalkonium Chloride 0.005%. Label includes dosage instructions and storage conditions. Distributed by Akorn in Gurnee, IL. Includes barcode and NDC 17478-715-10.*
FDA Label Image

Principal Display Panel Text For Carton Label (Bri01 0007 03)

Principal Display Panel Text For Carton Label (Bri01 0007 03)
Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a sterile 5 mL eye drop solution labeled for prescription use only. The label includes dosage instructions, storage conditions, and a list of active and inactive ingredients. It is distributed by Akorn Operating Company LLC, Gurnee, IL. The NDC on the label is 17478-715-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.